Trial Profile
A sprinkle formulation of lopinavir/ritonavir versus an oral solution formulation (Kaletra) in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2012
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lopinavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Cipla
- 15 Mar 2012 New trial record
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.